Old Web
English
Sign In
Acemap
>
Paper
>
ALPN-101 (Acazicolcept) a Dual ICOS/CD28 Antagonist, Demonstrates Efficacy in Systemic Sclerosis Preclinical Mouse Models
ALPN-101 (Acazicolcept) a Dual ICOS/CD28 Antagonist, Demonstrates Efficacy in Systemic Sclerosis Preclinical Mouse Models
2021
Cindy Orvain
Anne Cauvet
Alexis Prudent
Christophe Guignabert
Raphaël Thuillet
Mina Ottaviani
Ly Tu
Fanny Duhalde
Carole Nicco
Frédéric Batteux
Jérôme Avouac
NinXin Wang
Michelle A. Seaberg
Stacey R. Dillon
Yannick Allanore
Keywords:
Antagonist
CD28
Pharmacology
DUAL (cognitive architecture)
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]